1
|
Shin SH, Koh YG, Lee WG, Seok J, Park KY. The use of epidermal growth factor in dermatological practice. Int Wound J 2022. [PMID: 36584669 DOI: 10.1111/iwj.14075] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Revised: 12/14/2022] [Accepted: 12/21/2022] [Indexed: 12/31/2022] Open
Abstract
Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival, proliferation, migration, and differentiation. Exogenous administration of bioidentical human recombinant epidermal growth factor (rhEGF) has been known to promote skin wound healing, although rhEGF is increasingly being used in drug delivery systems and nanotechnology. However, despite considerable attention being focused on the potential clinical applications of rhEGF in several dermatological conditions beyond wound healing, the number of studies still remains relatively low. Herein, we conducted a literature search of PubMed/Medline and Google Scholar databases to retrieve published literature related to rhEGF and summarised the effects of rhEGF in the treatment of various wound types, radiotherapy or chemotherapy-related skin reactions, atopic dermatitis, skin aging, and post-inflammatory hyperpigmentation.
Collapse
Affiliation(s)
- Sun Hye Shin
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea
| | - Young Gue Koh
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea
| | - Woo Geon Lee
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea
| | - Joon Seok
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea
| | - Kui Young Park
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea
| |
Collapse
|
2
|
Goel R, Ojha H, Choudhary V, Sharma D, Nair A, Sharma N, Pathak M, Shivkumar H, Sharma R, Kaushik V, Singhal R. Medical management of ionizing radiation-induced skin injury. RADIATION PROTECTION AND ENVIRONMENT 2022. [DOI: 10.4103/rpe.rpe_4_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
3
|
Yang K, Kim SY, Park JH, Ahn WG, Jung SH, Oh D, Park HC, Choi C. Topical Application of Phlorotannins from Brown Seaweed Mitigates Radiation Dermatitis in a Mouse Model. Mar Drugs 2020; 18:md18080377. [PMID: 32707897 PMCID: PMC7460453 DOI: 10.3390/md18080377] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 07/17/2020] [Accepted: 07/20/2020] [Indexed: 12/22/2022] Open
Abstract
Radiation dermatitis (RD) is one of the most common side effects of radiotherapy; its symptoms progress from erythema to dry and moist desquamation, leading to the deterioration of the patients’ quality of life. Active metabolites in brown seaweed, including phlorotannins (PTNs), show anti-inflammatory activities; however, their medical use is limited. Here, we investigated the effects of PTNs in a mouse model of RD in vivo. X-rays (36 Gy) were delivered in three fractions to the hind legs of BALB/c mice. Macroscopic RD scoring revealed that PTNs significantly mitigated RD compared with the vehicle control. Histopathological analyses of skin tissues revealed that PTNs decreased epidermal and dermal thickness compared with the vehicle control. Western blotting indicated that PTNs augmented nuclear factor erythroid 2-related factor 2 (NRF2)/heme oxygenase-1 (HO-1) pathway activation but attenuated radiation-induced NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) and inflammasome activation, suggesting the mitigation of acute inflammation in irradiated mouse skin. PTNs also facilitated fast recovery, as indicated by increased aquaporin 3 expression and decreased γH2AX (histone family member X) expression. Our results indicate that topical PTN application may alleviate RD symptoms by suppressing oxidative stress and inflammatory signaling and by promoting the healing process. Therefore, PTNs may show great potential as cosmeceuticals for patients with cancer suffering from radiation-induced inflammatory side effects such as RD.
Collapse
Affiliation(s)
- Kyungmi Yang
- Department of Radiation Oncology, Samsung Medical Center, Seoul 06351, Korea; (K.Y.); (S.-Y.K.); (W.-G.A.); (S.H.J.); (D.O.)
- School of Medicine, Sungkyunkwan University, Seoul 06351, Korea;
| | - Shin-Yeong Kim
- Department of Radiation Oncology, Samsung Medical Center, Seoul 06351, Korea; (K.Y.); (S.-Y.K.); (W.-G.A.); (S.H.J.); (D.O.)
| | - Ji-Hye Park
- School of Medicine, Sungkyunkwan University, Seoul 06351, Korea;
- Department of Dermatology, Samsung Medical Center, Seoul 06351, Korea
| | - Won-Gyun Ahn
- Department of Radiation Oncology, Samsung Medical Center, Seoul 06351, Korea; (K.Y.); (S.-Y.K.); (W.-G.A.); (S.H.J.); (D.O.)
| | - Sang Hoon Jung
- Department of Radiation Oncology, Samsung Medical Center, Seoul 06351, Korea; (K.Y.); (S.-Y.K.); (W.-G.A.); (S.H.J.); (D.O.)
| | - Dongruyl Oh
- Department of Radiation Oncology, Samsung Medical Center, Seoul 06351, Korea; (K.Y.); (S.-Y.K.); (W.-G.A.); (S.H.J.); (D.O.)
- School of Medicine, Sungkyunkwan University, Seoul 06351, Korea;
| | - Hee Chul Park
- Department of Radiation Oncology, Samsung Medical Center, Seoul 06351, Korea; (K.Y.); (S.-Y.K.); (W.-G.A.); (S.H.J.); (D.O.)
- School of Medicine, Sungkyunkwan University, Seoul 06351, Korea;
- Correspondence: (H.C.P.); (C.C.); Tel.: +82-2-3110-2605 (H.C.P.); +82-6190-5331 (C.C.)
| | - Changhoon Choi
- Department of Radiation Oncology, Samsung Medical Center, Seoul 06351, Korea; (K.Y.); (S.-Y.K.); (W.-G.A.); (S.H.J.); (D.O.)
- Correspondence: (H.C.P.); (C.C.); Tel.: +82-2-3110-2605 (H.C.P.); +82-6190-5331 (C.C.)
| |
Collapse
|
4
|
Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: A review of the literature and proposal for treatment algorithm. J Am Acad Dermatol 2019; 81:558-567. [DOI: 10.1016/j.jaad.2019.02.047] [Citation(s) in RCA: 48] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2018] [Revised: 02/17/2019] [Accepted: 02/20/2019] [Indexed: 01/05/2023]
|
5
|
Kim M, Lee Y, Yoo Y, Choi J, Kim H, Kang C, Yu J, Moon S, Kim A, Kim C. Exogenous CLASP2 protein treatment enhances wound healing
in vitro
and
in vivo. Wound Repair Regen 2019; 27:345-359. [DOI: 10.1111/wrr.12713] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2018] [Revised: 11/16/2018] [Accepted: 11/27/2018] [Indexed: 12/31/2022]
Affiliation(s)
- MiJung Kim
- Division of Life SciencesCollege of Life Sciences and Biotechnology, Korea University 145 Anam‐dong, Sungbuk‐ku, Seoul 136701 South Korea
- Department of BiotechnologyCollege of Life Sciences and Biotechnology, Korea University 145 Anam‐dong, Sungbuk‐ku, Seoul 136701 South Korea
| | - You‐Sun Lee
- Department of BiotechnologyCollege of Life Sciences and Biotechnology, Korea University 145 Anam‐dong, Sungbuk‐ku, Seoul 136701 South Korea
| | - Yun‐Mi Yoo
- Department of BiotechnologyCollege of Life Sciences and Biotechnology, Korea University 145 Anam‐dong, Sungbuk‐ku, Seoul 136701 South Korea
| | - Jong‐Jin Choi
- Department of Stem Cell BiologySchool of Medicine, Konkuk University 120 Neungdong‐ro, Gwangjin‐gu, Seoul 143‐701 South Korea
| | - Ha‐Na Kim
- Department of Stem Cell BiologySchool of Medicine, Konkuk University 120 Neungdong‐ro, Gwangjin‐gu, Seoul 143‐701 South Korea
| | - Changhee Kang
- Department of Stem Cell BiologySchool of Medicine, Konkuk University 120 Neungdong‐ro, Gwangjin‐gu, Seoul 143‐701 South Korea
| | - Ji‐Min Yu
- R&D DivisionCHA Biotech Co. Ltd. 521 CHABIO Complex, 335 Pangyo‐ro, Bundang‐gu Gyeonggi‐Do South Korea
| | - Sung‐Hwan Moon
- Department of MedicineSchool of Medicine, Konkuk University 120 Neungdong‐ro, Gwangjin‐gu, Seoul 143‐701 South Korea
| | - Aeri Kim
- College of Pharmacy, CHA University 521 CHABIO Complex, 335 Pangyo‐ro, Bundang‐gu Gyeonggi‐Do South Korea
| | - Chan‐Wha Kim
- Division of Life SciencesCollege of Life Sciences and Biotechnology, Korea University 145 Anam‐dong, Sungbuk‐ku, Seoul 136701 South Korea
- Department of BiotechnologyCollege of Life Sciences and Biotechnology, Korea University 145 Anam‐dong, Sungbuk‐ku, Seoul 136701 South Korea
| |
Collapse
|
6
|
Miller ED, Song F, Smith JD, Ayan AS, Mo X, Weldon M, Lu L, Campbell PG, Bhatt AD, Chakravarti A, Jacob NK. Plasma-based biomaterials for the treatment of cutaneous radiation injury. Wound Repair Regen 2018; 27:139-149. [PMID: 30576033 PMCID: PMC7261420 DOI: 10.1111/wrr.12691] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Revised: 11/08/2018] [Accepted: 11/27/2018] [Indexed: 01/03/2023]
Abstract
Cutaneous wounds caused by an exposure to high doses of ionizing radiation remain a therapeutic challenge. While new experimental strategies for treatment are being developed, there are currently no off‐the‐shelf therapies for the treatment of cutaneous radiation injury that have been proven to promote repair of the damaged tissues. Plasma‐based biomaterials are biologically active biomaterials made from platelet enriched plasma, which can be made into both solid and semi‐solid forms, are inexpensive, and are available as off‐the‐shelf, nonrefrigerated products. In this study, the use of plasma‐based biomaterials for the mitigation of acute and late toxicity for cutaneous radiation injury was investigated using a mouse model. A 2‐cm diameter circle of the dorsal skin was irradiated with a single dose of 35 Gy followed by topical treatment with plasma‐based biomaterial or vehicle once daily for 5 weeks postirradiation. Weekly imaging demonstrated more complete wound resolution in the plasma‐based biomaterial vs. vehicle group which became statistically significant (p < 0.05) at weeks 12, 13, and 14 postmaximum wound area. Despite more complete wound healing, at 9 and 17 weeks postirradiation, there was no statistically significant difference in collagen deposition or skin thickness between the plasma‐based biomaterial and vehicle groups based on Masson trichrome staining nor was there a statistically significant difference in inflammatory or fibrosis‐related gene expression between the groups. Although significant improvement was not observed for late toxicity, plasma‐based biomaterials were effective at promoting wound closure, thus helping to mitigate acute toxicity.
Collapse
Affiliation(s)
- Eric D Miller
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| | - Feifei Song
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| | - Jason D Smith
- Engineering Research Accelerator, Carnegie Mellon University, Pittsburgh, Pennsylvania.,Carmell Therapeutics, Pittsburgh, Pennsylvania
| | - Ahmet S Ayan
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| | - Xiaokui Mo
- Center for Biostatistics, The Ohio State University, Columbus, Ohio
| | - Michael Weldon
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| | - Lanchun Lu
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| | - Phil G Campbell
- Engineering Research Accelerator, Carnegie Mellon University, Pittsburgh, Pennsylvania
| | - Aashish D Bhatt
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| | - Arnab Chakravarti
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| | - Naduparambil K Jacob
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
| |
Collapse
|
7
|
Ryu JW, Choe SS, Ryu SH, Park EY, Lee BW, Kim TK, Ha CH, Lee SW. Paradoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells. Oncotarget 2018; 8:4181-4195. [PMID: 27935858 PMCID: PMC5354822 DOI: 10.18632/oncotarget.13809] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Accepted: 11/24/2016] [Indexed: 12/12/2022] Open
Abstract
Epidermal growth factor (EGF) signaling promotes cell proliferation and survival in several types of cancer. Here, however, we showed that EGF inhibits proliferation and promotes programmed cell death in non-small cell lung cancer (NSCLC) cells. In A549 cells, EGF increased redox factor-1 (Ref-1) expression and the association of Ref-1 with zinc finger-containing transcriptional regulator (EGR1) via activation of p22phox, RAC1, and an NADPH oxidase subunit. EGF increased p22phox and RAC1 expression through activation of purinergic receptors (P2Y). Elevated Ref-1/EGR1 levels increased phosphatase and tensin homolog (PTEN) levels, leading to inhibition of the Akt pathway. EGF-induced PTEN upregulation increased apoptosis and autophagy-induced damage in A549 cells, whereas Ref-1 knockdown blocked EGF-induced PTEN upregulation in an NADPH oxidase p22phox subunit-independent manner. In addition, p22phox knockdown restored EGF-induced effects, implying that changes in P2Y activity caused by EGF, which activates NADPH oxidase via RAC1, influenced Ref-1-mediated redox regulation. Finally, EGF similarly attenuated cell proliferation and promoted autophagy and apoptosis in vivo in a xenograft model using A549 cells. These findings reveal that EGF-induced redox signaling is linked to Ref-1-induced death in NSCLC cells.
Collapse
Affiliation(s)
- Je-Won Ryu
- Department of Radiation Oncology, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Sung Sik Choe
- Department of Biological Sciences, Institute of Molecular Biology and Genetics, National Creative Research Institutive Center for Adipose Tissue Remodeling, Seoul National University, Seoul, Republic of Korea
| | - Seung-Hee Ryu
- Department of Radiation Oncology, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Eun-Young Park
- Department of Radiation Oncology, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Byoung Wook Lee
- Asan Institute for Life Science, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Tae Keun Kim
- Department of Life Science, College of Natural Science, Hallym University, Kyeongki Province, Republic of Korea
| | - Chang Hoon Ha
- Asan Institute for Life Science, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Sang-Wook Lee
- Department of Radiation Oncology, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
8
|
Chen J, Li H, Chen J. Human epidermal growth factor coupled to different structural classes of cell penetrating peptides: A comparative study. Int J Biol Macromol 2017; 105:336-345. [DOI: 10.1016/j.ijbiomac.2017.07.041] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2016] [Revised: 04/30/2017] [Accepted: 07/06/2017] [Indexed: 12/25/2022]
|
9
|
The effects of enteral glutamine on radiotherapy induced dermatitis in breast cancer. Clin Nutr 2016; 35:436-439. [DOI: 10.1016/j.clnu.2015.03.009] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2014] [Revised: 03/08/2015] [Accepted: 03/12/2015] [Indexed: 01/29/2023]
|
10
|
Zhou J, Fang L, Xie H, Yao WX, Zhou X, Xiong ZJ. A pilot study using the Chinese herbal paste Liu-He-Dan to manage radiodermatitis associated with breast cancer radiotherapy. ACTA ACUST UNITED AC 2015; 22:e453-6. [PMID: 26715882 DOI: 10.3747/co.22.2725] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND During radiotherapy for breast cancer, patients are greatly affected by pain, infection, and delayed healing of wounds caused by radiodermatitis. In the present study, we aimed to determine the efficacy of Liu-He-Dan in treating radiodermatitis. METHODS In 26 breast cancer patients who experienced moist decrustation while receiving radiotherapy, 5 g Liu-He-Dan was applied externally once daily after the wound surface had been cleaned and dried. The healing time was recorded, and a Kaplan-Meier survival curve was applied to analyze the treatment course. Meanwhile, a pain assessment using the Numeric Rating Scale (nrs) recorded the pain level experienced by patients after application of the Liu-He-Dan. RESULTS After application of Liu-He-Dan, the average healing time for the surface of the moist decrustation wounds was 14.17 ± 2.03 days (range: 5-22 days). Inflammatory seepage decreased significantly and exudation almost disappeared in 3 days. The pain trend line indicated that the average nrs score declined with treatment in all patients. The average nrs scores at days 1, 4, and 7 were 6.13, 3.62, and 2.58 respectively. After 3 days of treatment, pain was remarkably alleviated in 80.76% of patients. After treatment for 1 week, the pain remission rate was 96.15%, without any obvious adverse reactions. CONCLUSIONS Liu-He-Dan was efficacious in treating radiation skin injury with little toxicity and few side effects; the economic efficiency of the treatment was also favourable. The Liu-He-Dan was generally well tolerated by patients. In future, randomized control trials will be established for further observation of the value of Liu-He-Dan in treating radiodermatitis in breast cancer.
Collapse
Affiliation(s)
- J Zhou
- Department of Chemotherapy, Sichuan Cancer Hospital, Chengdu, Sichuan, P.R.C
| | - L Fang
- Department of Gastroenterology, The First Affiliated Hospital, Chengdu Medical College, Chengdu, Sichuan, P.R.C
| | - H Xie
- Department of Chemotherapy, Sichuan Cancer Hospital, Chengdu, Sichuan, P.R.C
| | - W X Yao
- Department of Chemotherapy, Sichuan Cancer Hospital, Chengdu, Sichuan, P.R.C
| | - X Zhou
- Department of Chemotherapy, Sichuan Cancer Hospital, Chengdu, Sichuan, P.R.C
| | - Z J Xiong
- Department of Chemotherapy, Sichuan Cancer Hospital, Chengdu, Sichuan, P.R.C
| |
Collapse
|
11
|
Ogino S, Morimoto N, Sakamoto M, Jinno C, Taira T, Suzuki S. Efficacy of gelatin gel sheets sustaining epidermal growth factor for murine skin defects. J Surg Res 2015; 201:446-54. [PMID: 27020831 DOI: 10.1016/j.jss.2015.11.027] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2015] [Revised: 10/05/2015] [Accepted: 11/18/2015] [Indexed: 11/28/2022]
Abstract
BACKGROUND Epidermal growth factor (EGF) plays an important role in wound healing. However, EGF must be applied daily due to rapid inactivation in vivo. We investigated the sustained release of EGF from gelatin gel sheets (GGSs) and the efficacy of GGSs impregnated with EGF for promoting wound healing. MATERIALS AND METHODS GGSs impregnated with EGF were prepared by cross-linking via glutaraldehyde to gelatin solution containing EGF. The sustained release of EGF and the bioactivity of released EGF were evaluated. Then, three kinds of GGSs containing NSS (normal saline solution; NSS group), 2.5 μg of EGF (EGF-L group), or 25 μg of EGF (EGF-H group) were applied to full-thickness skin defects created on the backs of mice. The wounds covered with polyurethane film without GGS were used as a control (PUF group). The wound area, neoepithelium length, regenerated granulation tissue, and newly formed capillaries were evaluated. RESULTS EGF was sustained and released from GGS as it degraded. The bioactivity of released EGF was confirmed. EGF-L group promoted the neoepithelium length, regenerated granulation tissue, and newly formed capillaries compared with those in the PUF and NSS groups. The area of regenerated granulation tissue in the NSS group (week 1: 2.6 + 0.2 mm(2), week 2: 2.8 + 0.3 mm(2)) was larger than that in the PUF group (week 1: 0.6 + 0.1 mm(2), week 2: 1.0 + 0.1 mm(2)). The area of newly formed capillaries in the EGF-L group (9967 + 1903 μm(2)) was larger than that of the EGF-H group (3485 + 1050 μm(2)). CONCLUSIONS GGSs impregnated with EGF-L showed promising results regarding wound healing.
Collapse
Affiliation(s)
- Shuichi Ogino
- Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Naoki Morimoto
- Department of Plastic and Reconstructive Surgery, Kansai Medical University, Hirakata, Japan.
| | - Michiharu Sakamoto
- Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Chizuru Jinno
- Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | | | - Shigehiko Suzuki
- Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| |
Collapse
|
12
|
Kang HC, Ahn SD, Choi DH, Kang MK, Chung WK, Wu HG. The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiat Oncol J 2014; 32:156-62. [PMID: 25324987 PMCID: PMC4194298 DOI: 10.3857/roj.2014.32.3.156] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Revised: 06/24/2014] [Accepted: 08/11/2014] [Indexed: 12/24/2022] Open
Abstract
Purpose This study was designed to evaluate the efficacy and safety of topically applied recombinant human epidermal growth factor (rhEGF) for the prevention of radiation-induced dermatitis in cancer patients. Materials and Methods From December 2010 to April 2012, a total of 1,172 cancer patients who received radiotherapy (RT) of more than 50 Gy were prospectively enrolled and treated with EGF-based cream. An acute skin reaction classified according to the Radiation Therapy Oncology Group 6-point rating scale was the primary end point and we also assessed the occurrence of edema, dry skin, or pruritus. Results The percentage of radiation dermatitis with maximum grade 0 and grade 1 was 19% and 58% at the time of 50 Gy, and it became 29% and 47% after completion of planned RT. This increment was observed only in breast cancer patients (from 18%/62% to 32%/49%). Adverse events related to the EGF-based cream developed in 49 patients (4%) with mild erythema the most common. Skin toxicity grade >2 was observed in 5% of the patients. Edema, dry skin, and pruritus grade ≥3 developed in 9%, 9%, and 1% of the patients, respectively. Conclusion Prophylactic use of an EGF-based cream is effective in preventing radiation dermatitis with tolerable toxicity. Further studies comparing EGF cream with other topical agents may be necessary.
Collapse
Affiliation(s)
- Hyun-Cheol Kang
- Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea. ; Department of Radiation Oncology, Dongnam Institute of Radiological and Medical Sciences, Busan, Korea
| | - Seung-Do Ahn
- Department of Radiation Oncology, Asan Medical Center, Seoul, Korea
| | - Doo-Ho Choi
- Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea
| | - Min Kyu Kang
- Department of Radiation Oncology, Yeungnam University College of Medicine, Daegu, Korea
| | - Woong-Ki Chung
- Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Huasun, Korea
| | - Hong-Gyun Wu
- Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea
| |
Collapse
|
13
|
Lee J, Lee SW, Hong JP, Shon MW, Ryu SH, Ahn SD. Foam dressing with epidermal growth factor for severe radiation dermatitis in head and neck cancer patients. Int Wound J 2014; 13:390-3. [PMID: 24947011 DOI: 10.1111/iwj.12317] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2014] [Revised: 05/22/2014] [Accepted: 05/25/2014] [Indexed: 11/30/2022] Open
Abstract
This study was conducted to evaluate the effects of foam dressing with human recombinant human epidermal growth factor (rhEGF) on the healing process in head and neck cancer patients who experience radiation-induced dermatitis (RID). Seven patients, including three with oropharyngeal, two with nasopharyngeal and one each with hypopharyngeal and laryngeal carcinoma, who underwent radiotherapy (RT) for head and neck cancer at the Asan Medical Center from March to December 2008 were prospectively included in this study. Patients who showed severe RID (more than wet desquamation) on the supraclavicular fossa or neck areas were treated by wound cleaning and debridement of granulation tissue, followed by daily rhEGF spray and foam dressing. Median time to stop exudates and reepithelialisation was 4 days. Within 14 days (median 8 days), all patients showed complete healing of RID and no longer required dressings. This new method of treatment with dressing containing rhEGF may have the potential to accelerate the healing process in patients with RID. A case-control study is needed to confirm this finding.
Collapse
Affiliation(s)
- Jihyo Lee
- Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea
| | - Sang-Wook Lee
- Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea
| | - Joon Pio Hong
- Department of Plastic and Reconstructive Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea
| | - Myeong Wha Shon
- Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea
| | - Seung-Hee Ryu
- Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea
| | - Seung Do Ahn
- Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea
| |
Collapse
|
14
|
Kong M, Hong SE. Topical Use of Recombinant Human Epidermal Growth Factor (EGF)-Based Cream to Prevent Radiation Dermatitis in Breast Cancer Patients: a Single-Blind Randomized Preliminary Study. Asian Pac J Cancer Prev 2013; 14:4859-64. [DOI: 10.7314/apjcp.2013.14.8.4859] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
15
|
Haubner F, Ohmann E, Pohl F, Strutz J, Gassner HG. Wound healing after radiation therapy: review of the literature. Radiat Oncol 2012; 7:162. [PMID: 23006548 PMCID: PMC3504517 DOI: 10.1186/1748-717x-7-162] [Citation(s) in RCA: 262] [Impact Index Per Article: 21.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2012] [Accepted: 09/20/2012] [Indexed: 12/19/2022] Open
Abstract
Radiation therapy is an established modality in the treatment of head and neck cancer patients. Compromised wound healing in irradiated tissues is a common and challenging clinical problem. The pathophysiology and underlying cellular mechanisms including the complex interaction of cytokines and growth factors are still not understood completely. In this review, the current state of research regarding the pathomechanisms of compromised wound healing in irradiated tissues is presented. Current and possible future treatment strategies are critically reviewed.
Collapse
Affiliation(s)
- Frank Haubner
- Department of Otorhinolaryngology, Division of Facial Plastic Surgery, University of Regensburg, Regensburg, Germany.
| | | | | | | | | |
Collapse
|